Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Chemotherapy Maintenance in mCRC
NCT01668680Phase 2Terminated
- Sponsor
- Emek Medical Center
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, celecoxib oral solution, methotrexate in colorectal cancer (metastatic) (mCRC), sponsored by Emek Medical Center. Started Sep 2012; status: terminated.
02
Drugs
capecitabinecelecoxib oral solutionmethotrexate
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01668680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668680.